ArticleStem cell research & therapy2020

CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.

Ji-Young Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.